Caffeic acid methyl and ethyl esters exert potential antidiabetic effects on glucose and lipid metabolism in cultured murine insulin-sensitive cells through mechanisms implicating activation of AMPK

References

• Bijland S, Mancini SJ, Salt IP. 2013. Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin Sci. 124:491–507.
   PubMed Web of Science ®Google Scholar
• Celik S, Erdogan S, Tuzcu M. 2009. Caffeic acid phenethyl ester (CAPE) exhibits significant potential as an antidiabetic and liver-protective agent in streptozotocin-induced diabetic rats. Pharmacol Res. 60:270–276.
   PubMed Web of Science ®Google Scholar
• Cushman SW, Goodyear LJ, Pilch PF, Ralston E, Galbo H, Ploug T, Kristiansen S, Klip A. 1998. Molecular mechanisms involved in GLUT4 translocation in muscle during insulin and contraction stimulation. Adv Exp Med Biol. 441:63–71.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tripathy D. 2009. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 32:S157–S163.
   PubMed Web of Science ®Google Scholar
• Eid HM, Martineau LC, Saleem A, Muhammad A, Vallerand D, Benhaddou-Andaloussi A, Nistor L, Afshar A, Arnason JT, Haddad PS. 2010. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol Nutr Food Res. 54:991–1003.
   PubMed Web of Science ®Google Scholar
• Eid HM, Vallerand D, Muhammad A, Durst T, Haddad PS, Martineau LC. 2010. Structural constraints and the importance of lipophilicity for the mitochondrial uncoupling activity of naturally occurring caffeic acid esters with potential for the treatment of insulin resistance. Biochem Pharmacol. 1:444–454.
   Google Scholar
• Eid HMM. 2010. Antidiabetic activity of Vaccinium vitis-idaea, a medicinal plant from the traditional pharmacopeia of the James Bay Cree [Ph.D.]. Montreal: University of Montreal.
   Google Scholar
• Flach RJR, Bennett AM. 2010. Mitogen-activated protein kinase phosphatase-1 – a potential therapeutic target in metabolic disease. Expert Opin Ther Targets. 14:1323–1332.
   PubMed Web of Science ®Google Scholar
• Gao YY, Zhou AX, Wu D. 2008. Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cells. Biol Pharm Bull. 31:1716–1722.
   PubMed Web of Science ®Google Scholar
• IDF. 2014. IDF Atlas Sixth Edition Poster Update. International Diabetes Federation. http://www.idf.org/diabetesatlas/update-2014
   Google Scholar
• James DE, Strube M, Mueckler M. 1989. Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature. 2:83–87.
   Google Scholar
• Jung UJ, Choi MS. 2014. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. IJMS. 15:6184–6223.
   Google Scholar
• Kang JG, Park C-Y. 2012. Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J. 36:13–25.
   PubMedGoogle Scholar
• Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, Jang WG, Cho WJ, Ha J, Lee IK, et al. 2008. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes. 57:306–314.
   PubMed Web of Science ®Google Scholar
• LeBlanc LM, Pare AF, Jean-Francois J, Hebert MJ, Surette ME, Touaibia M. 2012. Synthesis and antiradical/antioxidant activities of caffeic acid phenethyl ester and its related propionic, acetic, and benzoic acid analogues. Molecules. 10:14637–14650.
   Google Scholar
• Lee ES, Uhm KO, Lee YM, Han M, Lee M, Park JM, Suh PG, Park SH, Kim HS. 2007. CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cells. Biochem Biophys Res Commun. 5:854–858.
   Google Scholar
• Martineau LC, Herve J, Muhamad A, Saleem A, Harris CS, Arnason JT, Haddad PS. 2010. Anti-adipogenic activities of Alnus incana and Populus balsamifera bark extracts, part I: sites and mechanisms of action. Planta Med. 76:1439–1446.
   PubMed Web of Science ®Google Scholar
• McGee SL, van Denderen BJ, Howlett KF, Mollica J, Schertzer JD, Kemp BE, Hargreaves M. 2008. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes. 57:860–867.
   PubMed Web of Science ®Google Scholar
• Mungai PT, Waypa GB, Jairaman A, Prakriya M, Dokic D, Ball MK, Schumacker PT. 2011. Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels. Mol Cell Biol. 31:3531–3545.
   PubMed Web of Science ®Google Scholar
• Nachar A, Vallerand D, Musallam L, Lavoie L, Badawi A, Arnason J, Haddad PS. 2013. The action of antidiabetic plants of the Canadian James Bay Cree traditional pharmacopeia on key enzymes of hepatic glucose homeostasis. Evid Based Complement Alternat Med. 2013:189819
   PubMed Web of Science ®Google Scholar
• Niu W, Huang C, Nawaz Z, Levy M, Somwar R, Li D, Bilan PJ, Klip A. 2003. Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis. J Biol Chem. 16:17953–17962.
   Google Scholar
• Osler ME, Zierath JR. 2008. Adenosine 5'-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology. 149:935–941.
   PubMed Web of Science ®Google Scholar
• Pascual JM, Wang D, Lecumberri B, Yang H, Mao X, Yang R, De Vivo DC. 2004. GLUT1 deficiency and other glucose transporter diseases. Eur J Endocrinol. 150:627–633.
   PubMed Web of Science ®Google Scholar
• Roberts CK, Hevener AL, Barnard RJ. 2013. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 3:1–58.
   PubMed Web of Science ®Google Scholar
• Ruderman NB, Park H, Kaushik VK, Dean D, Constant S, Prentki M, Saha AK. 2003. AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta Physiol Scand. 178:435–442.
   PubMedGoogle Scholar
• Simpson RJ. 2008. Quantifying protein by bicinchoninic Acid. CSH Protoc. 1:2008. pdb prot4722.
   Google Scholar
• Smith SM, Wunder MB, Norris DA, Shellman YG. 2011. A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time. PLoS One. 6:e26908.
   PubMed Web of Science ®Google Scholar
• Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM. 2012. Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol. 2012:983814.
   PubMed Web of Science ®Google Scholar
• Tortorella LL, Pilch PF. 2002. C2C12 myocytes lack an insulin-responsive vesicular compartment despite dexamethasone-induced GLUT4 expression. Am J Physiol Endocrinol Metab. 283:E514–E524.
   PubMed Web of Science ®Google Scholar
• Verhey KJ, Yeh JI, Birnbaum MJ. 1995. Distinct signals in the GLUT4 glucose transporter for internalization and for targeting to an insulin-responsive compartment. J Cell Biol. 130:1071–1079.
   PubMed Web of Science ®Google Scholar
• Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. 2012. Cellular and molecular mechanisms of metformin: an overview. Clin Sci. 122:253–270.
   PubMed Web of Science ®Google Scholar
• WHO. 2015. Diabetes Fact sheet No. 312. World Health Organization. http://www.who.int/mediacentre/factsheets/fs312/en/
   Google Scholar